GenVec (GNVC) Updates on CGF166 Phase 1/2; DSMB Recommends Trial Continue, Subject to Approval (NVS)
Tweet Send to a Friend
GenVec, Inc. (Nasdaq: GNVC) announced that it was notified by its collaborator Novartis that the Data Safety Monitoring Board (DSMB) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE